According to Biolase 's latest financial reports the company's current EPS (TTM) is -โน22,627. In 2022 the company made an earnings per share (EPS) of -โน35,101 a decrease over its 2021 EPS that were of -โน22,845.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน21,766 | -37.99% |
2022 | -โน35,101 | 53.65% |
2021 | -โน22,845 | -81.87% |
2020 | -โน1,25,978 | -25.32% |
2019 | -โน1,68,683 | -24.76% |
2018 | -โน2,24,199 | -26.06% |
2017 | -โน3,03,202 | 4.33% |
2016 | -โน2,90,628 | -14.71% |
2015 | -โน3,40,736 | -26.09% |
2014 | -โน4,60,996 | 35.41% |
2013 | -โน3,40,437 | 244.31% |
2012 | -โน98,875 | -38.05% |
2011 | -โน1,59,616 | -64.8% |
2010 | -โน4,53,420 | 347.66% |
2009 | -โน1,01,287 | -71.05% |
2008 | -โน3,49,899 | 22.58% |
2007 | -โน2,85,444 | 55% |
2006 | -โน1,84,157 | -74.03% |
2005 | -โน7,09,006 | -22.22% |
2004 | -โน9,11,579 | -208.79% |
2003 | โน8,37,916 | 1720% |
2002 | โน46,039 | -171.43% |
2001 | -โน64,455 | -65% |
2000 | -โน1,84,157 | -28.57% |
1999 | -โน2,57,820 | -56.92% |
1998 | -โน5,98,512 | 209.52% |
1997 | -โน1,93,365 | 5% |
1996 | -โน1,84,157 |